CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

Determining Whether to Submit an ANDA or a 505(b)(2) Application

RegulatoryNeutral
AI Analysis

Summary

FDA guidance document on determining whether to submit an ANDA or 505(b)(2) application. No specific company, drug, or clinical developments mentioned.

Importance:1/10
Sentiment:
0.00
regulatory_guidanceANDA505b2_applicationFDA

Read the original article

Published by FDA Drugs (New Approvals & NDA) on August 17, 2026 5:12 PM

Read Original